Effects of Corpus Luteum on Frozen Embryo Transfer Pregnancies
Official title: Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET): a Prospective Randomized Controlled Study
Run by Fundacion Clinic per a la Recerca Biomédica · NCT06896617 · Data updated 2026-11-12
This study is testing how the corpus luteum affects pregnancies from frozen embryo transfers to see if it influences things like heart health and fetal growth.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 41 Years |
| Sex | Women only |
| Enrollment | 334 (estimated) |
| Sponsor | Fundacion Clinic per a la Recerca Biomédica Academic / other |
| Locations | 1 site (Barcelona, Spain) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | November 20, 2026 |
| Study ends | December 20, 2026 |
| Registry record updated | April 2, 2025 |
| Trial ID | NCT06896617 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are females aged 18-37 with regular menstrual cycles and available cryopreserved blastocysts for single embryo transfer.
✕Probably not a fit
Patients with recurrent pregnancy loss, recurrent implantation failure, or certain medical conditions such as polycystic ovarian syndrome or autoimmune diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of the corpus luteum on pregnancies achieved through programmed frozen embryo transfer (PC-FET) and modified natural frozen embryo transfer (mNC-FET). It aims to assess differences in endothelial and placental function, maternal cardiovascular function, fetal growth, and fetal cardiovascular and cerebral programming. The study will also explore the relationship between these differences and the plasma concentrations of key secretion products from the corpus luteum that have vasoactive and angiogenic properties.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of how the corpus luteum affects pregnancy outcomes, potentially leading to improved fertility treatments.
How similar studies have gone: While there is limited information on similar studies, the investigation of the corpus luteum's role in pregnancy outcomes is a relevant area of research that has shown promise in related contexts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients 18- 37 years old (both included) at the time of oocyte retrieval and less than 41 years of age at the time of embryo transfer. * Regular menstrual cycles between 24 and 35 days. * Availability of cryopreserved blastocysts from own gametes * Indication for single embryo transfer. * Patients who will be included in the LUTI study are candidates for either of the two procedures under study, and will have no contraindications for either procedure. Exclusion Criteria: * Recurrent pregnancy loss (3 or more). * Recurrent implantation failure in previous IVF treatments (3 or more unsuccessful embryo transfers). . * Diagnosis of polycystic ovarian syndrome, diabetes mellitus, chronic arterial hypertension, maternal heart disease and autoimmune diseases (Systemic Lupus Erythematosus (SLE) or Antiphospholipid syndrome (APS)). * Active treatment with aspirin, heparin or other anticoagulant therapy, antihypertensives or other drugs used to treat circulation or coagulation disorders . * Indication for PGT (Preimplantation Genetic Testing). * Multiple pregnancy.
Where it's running
-
Laura Burunat
Barcelona, Spain, Spain Recruiting
Study contacts
- Study coordinator: Laura B Burunat, Graduate
- Email: burunat@recerca.clinic.cat
- Phone: 0034932275400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pentoxifylline to improve uterine lining and frozen embryo transfer outcomes
This trial sees if giving pentoxifylline alongside standard estradiol helps women with good-quality day‑5 frozen embryos get a thicker uterine lining and better frozen embryo transfer success.
-
Triggering ovulation at smaller versus larger follicle sizes in a modified natural cycle
This trial tests whether triggering ovulation when follicles are 13–16.9 mm works as well as triggering at 17–22 mm for people having a modified natural cycle frozen embryo transfer.
-
New method for embryo transfer using a semi-automated system
This study is testing a new semi-automated system for embryo transfer to see if it can make the IVF process more precise and improve success rates for women trying to conceive.
-
Comparing letrozole and artificial cycles for preparing the uterus in women with irregular periods
This study is testing if using letrozole to prepare the uterus can help women with irregular periods have more successful pregnancies after freezing and transferring embryos compared to using an artificial hormone cycle.
-
Investigating the impact of sexual intercourse on embryo transfer outcomes
This study is testing if having sex the night after a frozen embryo transfer helps improve the chances of pregnancy for women undergoing this procedure.
-
Preventing pre-eclampsia with low-dose aspirin in women after frozen embryo transfer
This study is testing if taking low-dose aspirin can help prevent pre-eclampsia in pregnant women who have had a frozen embryo transfer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.